Moderna Tapped for $50 Million mRNA Sprint to Combat Bundibugyo Ebola Outbreak
CEPI has allocated $50 million to Moderna to accelerate an mRNA vaccine for the Bundibugyo ebolavirus as an outbreak surges in the DRC.
Tag: mRNA
Moderna Tapped for $50 Million mRNA Push Against Bundibugyo Ebola Strain
The U.S. government is accelerating mRNA vaccine development for the Bundibugyo virus as Ebola outbreaks persist, granting Moderna $50 million for rapid prototyping.
Moderna’s Personalized mRNA Vaccine Slashes Melanoma Recurrence Risk in Five-Year Trial
New clinical trial data reveals a personalized mRNA vaccine from Moderna significantly reduces the risk of melanoma returning and metastasizing over five years.